CTO0303

· Taejoon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTO0303, covering 2024-09-24 to 2024-09-24. Get the full timeline:

Most recent: Clinical Trial Update: Comparing Efficacy and Safety of CTO0303 in Pediatric Subjects [Phase 2, Phase 3]